drugset / Trial / NCT07816575

Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque Psoriasis

NCT07816575 ↗

Completed 80 enrolled Al-Azhar University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this double blind comparative clinical study is to evaluate the efficacy of AHAs combined with nanocarriers and their use as a non steroidal alternative drug for long term management of plaque psoriasis

Timeline

Start
2024-03-15
Primary completion
2025-07-03
Completion
2025-09-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified — Topical
Comparator Calcipotriol Small molecule — Topical

Indications